IFP Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

IFP Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2K	Buy	125 +75	+150%	+$1.08K	﹤0.01%	2135
2018 Q4	$1K	Hold	50	–	–	﹤0.01%	3420
2018 Q3	$2K	Hold	50	–	–	﹤0.01%	3602
2018 Q2	$1K	Buy	+50	New	+$1.11K	﹤0.01%	3792
2016 Q2	–	Sell	-125	Closed	-$2K	–	4115
2016 Q1	$2K	Buy	+125	New	+$2.65K	﹤0.01%	2128

Other funds holding MRNS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

IFP Advisors's MRNS Position: Q1 2019 in Review

IFP Advisors increased its Marinus Pharmaceuticals, Inc (MRNS) stake by 150% in Q1 2019, buying an estimated $1.08K and bringing the position to 125 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2135.

IFP Advisors first reported a position in MRNS in Q1 2016 and has held it in 5 quarters since. 81 funds tracked by Wall St. Rank hold MRNS as of Q1 2019.

IFP Advisors held 125 shares of Marinus Pharmaceuticals, Inc worth $2K as of Q1 2019.
IFP Advisors bought 75 Marinus Pharmaceuticals, Inc shares in Q1 2019, an estimated $1.08K.
Marinus Pharmaceuticals, Inc made up ﹤0.01% of IFP Advisors's portfolio in Q1 2019, its #2135 holding.
IFP Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q1 2016 and has held it in 5 quarters since.
81 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.